A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1)

Overview of attention for article published in Prostate Cancer and Prostatic Diseases, January 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 3 news outlets
twitter: 12 X users

reddit: 1 Redditor

Readers on

mendeley: 35 Mendeley

So far, Altmetric has seen 14 X posts from 12 X users, with an upper bound of 38,144 followers.

A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1) by Marijo Bilusic https://t.co/VRKBuY5Kxe

A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1) by Marijo Bilusic https://t.co/L3289BUjtz

RT @mbilusic: Hot off the press: A phase 2 study of bicalutamide+/-metformin in BCR prostate cancer (BIMET-1) https://t.co/zGRjtDdXWq @Dr_…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 10 additional X posts.